Daily intake of probiotic strain DE111 supports a healthy microbiome in children attending day-care.

Benef Microbes

Deerland Probiotics and Enzymes, UCC BioInnovation Unit, 1 College Road, Cork, Ireland.

Published: November 2020

There is ample evidence suggesting that modulations in gut microbiota play an important role in inflammation and immunity. In particular, the microbiota of children is highly susceptible to environment influences, such as infections. Consequently, probiotics and their ability to promote and support a healthy microbiome have been increasingly studied. This study aimed at investigating the effects of a probiotic supplement ( DE111) on the microbiome composition of preschool aged children attending day care. Healthy children aged 2-6 years old were randomised to receive either probiotic or placebo once a day for 8 weeks. No significant changes of the overall microbiome equilibrium were seen in between the two groups or from baseline to week 8. However, alpha diversity was increased in the probiotic group from baseline to week 8 (<0.05), with no change in the placebo group. A decrease in the / ratio following probiotic supplementation (<0.05) was also observed. Differential abundance analysis revealed an increase in (<0.01), (<0.05), (<0.01), (<0.001) and (<0.001) in the probiotic group, most of which are involved in inflammation reduction. In addition, a decrease in (<0.001), (<0.01) and (<0.01), which is considered pro-inflammatory, were also observed in the probiotic group. Together with a reduction of the F/B ratio observed in the probiotic group, these results suggest probiotic supplementation with DE111 introduce subtle but positive changes in the microbiome of children aged 2-6 years old.

Download full-text PDF

Source
http://dx.doi.org/10.3920/BM2020.0022DOI Listing

Publication Analysis

Top Keywords

healthy microbiome
8
children attending
8
baseline week
8
daily intake
4
probiotic
4
intake probiotic
4
probiotic strain
4
strain de111
4
de111 supports
4
supports healthy
4

Similar Publications

Evaluation of variations in predominant gut microbiota members in inflammatory bowel disease using real-time PCR.

Mol Biol Rep

January 2025

Department of Internal Medicine, Faculty of Medicine, Urmia University of Medical Sciences, Imam Khomeini Hospital, Urmia, Iran.

Inflammatory Bowel Disease (IBD) is a persistent ailment that impacts many individuals worldwide. The interaction between the immune system and gut microbiome is thought to influence IBD development. This study aimed to assess some microbiota in IBD patients compared to healthy individuals.

View Article and Find Full Text PDF

Unlabelled: Despite the prevalence and severity of enterococcal bacteremia (EcB), the mechanisms underlying systemic host responses to the disease remain unclear. Here, we present an extensive study that profiles molecular differences in plasma from EcB patients using an unbiased multi-omics approach. We performed shotgun proteomics and metabolomics on 105 plasma samples, including those from EcB patients and healthy volunteers.

View Article and Find Full Text PDF

Objectives: Inflammatory bowel disease (IBD) results from genetic susceptibility, gut microbiome, and environmental factors. Diet, one modifiable environmental factor, has been linked to the increased prevalence of IBD. This study aimed to evaluate a potential association between food deserts and disease severity at diagnosis.

View Article and Find Full Text PDF

Introduction: The current understanding of colorectal carcinogenesis is based on the adenoma-carcinoma sequence, where genetics, intestinal microbiota changes and local immunity shifts seem to play the key roles. Despite the emerging evidence of dysbiotic intestinal state and immune-cell infiltration changes in patients with colorectal adenocarcinoma, early and advanced adenoma as precursors of colorectal cancer, and carcinoma as the following progression, are rather less studied. The newly colon-site adapted AI-based analysis of immune infiltrates is able to predict long-term outcomes of colon carcinoma.

View Article and Find Full Text PDF

Equine pastern dermatitis (EPD) is a multifactorial disease with a change in the skin microbiome. The present study monitored the influence of Biocenol™ 4/8 D37 CCM 9015 stabilized on alginite on the skin microbiota of healthy horses and model patients with EPD. Based on clinical signs, EPD lesions were identified as exudative or proliferative forms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!